glp 1 non alcoholic fatty liver Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic disease: could the combinations of an old friend with new players yield better outcomes? GLP-1 Receptor Agonists in Non-Alcoholic

Szabo S, et al

Know Your Goals It helps to come prepared with a clear understanding of what you hope to achieve

Children assigned to the CRWP group showed significant increases in glutathione levels ( p = 0.04) compared to those in the placebo group

63% of patients achieved more than 20% weight loss compared to 1% on lifestyle changes alone

GLP-1 drugs covered under the Bridge include tirzepatide (Zepbound, Foundayo) and semaglutide (Wegovy), prescribed specifically for weight loss

Psst - looking to use the mighty RP2350 microcontroller as the brains in your project, but want more features than are present on a vanilla Raspberry Pi Pico 2